These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10367337)

  • 1. The enigma of arsenic carcinogenesis: role of metabolism.
    Goering PL; Aposhian HV; Mass MJ; Cebrián M; Beck BD; Waalkes MP
    Toxicol Sci; 1999 May; 49(1):5-14. PubMed ID: 10367337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update.
    Stýblo M; Drobná Z; Jaspers I; Lin S; Thomas DJ
    Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):767-71. PubMed ID: 12426129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression.
    Zhao CQ; Young MR; Diwan BA; Coogan TP; Waalkes MP
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10907-12. PubMed ID: 9380733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gene expression profiles in HepG2 cells exposed to arsenic, cadmium, nickel, and three model carcinogens for investigating the mechanisms of metal carcinogenesis.
    Kawata K; Shimazaki R; Okabe S
    Environ Mol Mutagen; 2009 Jan; 50(1):46-59. PubMed ID: 19031421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.
    Waalkes MP; Liu J; Ward JM; Diwan BA
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):377-84. PubMed ID: 15276417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of As3mt and Mth1 in the genotoxic and carcinogenic effects induced by long-term exposures to arsenic in MEF cells.
    Barguilla I; Peremartí J; Bach J; Marcos R; Hernández A
    Toxicol Appl Pharmacol; 2020 Dec; 409():115303. PubMed ID: 33141059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular metabolism and systemic toxicity of arsenic.
    Thomas DJ; Styblo M; Lin S
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):127-44. PubMed ID: 11601889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer.
    Cui X; Kobayashi Y; Akashi M; Okayasu R
    Curr Med Chem; 2008; 15(22):2293-304. PubMed ID: 18781951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic toxicity and potential mechanisms of action.
    Hughes MF
    Toxicol Lett; 2002 Jul; 133(1):1-16. PubMed ID: 12076506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, metabolism, and carcinogenicity of arsenic.
    Pott WA; Benjamin SA; Yang RS
    Rev Environ Contam Toxicol; 2001; 169():165-214. PubMed ID: 11330077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
    Kitchin KT
    Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes.
    Zhou Q; Xi S
    Regul Toxicol Pharmacol; 2018 Nov; 99():78-88. PubMed ID: 30223072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation.
    Waalkes MP; Liu J; Ward JM; Diwan BA
    Toxicology; 2004 May; 198(1-3):31-8. PubMed ID: 15138027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomethylation of DNA: a possible epigenetic mechanism involved in tumor promotion.
    Counts JL; Goodman JI
    Prog Clin Biol Res; 1995; 391():81-101. PubMed ID: 8532739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity.
    Aposhian HV
    Annu Rev Pharmacol Toxicol; 1997; 37():397-419. PubMed ID: 9131259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Historical perspective on the role of cell proliferation in carcinogenesis for DNA-reactive and non-DNA-reactive carcinogens: Arsenic as an example.
    Cohen JM; Beck BD; Rhomberg LR
    Toxicology; 2021 May; 456():152783. PubMed ID: 33872731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation.
    Reichard JF; Puga A
    Epigenomics; 2010 Feb; 2(1):87-104. PubMed ID: 20514360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.